The ALS Association provides the latest research news & information relevant to the fight against this disease through press releases, blog posts, research webinars, newsletters and more.
United States of America
ALS Untangled
ALSUntangled reviews alternative and off label treatments (AOTs), with the goal of helping people with ALS make more informed decisions about them.
Carers Hub
Our Carers hub is here to help if you provide unpaid support to someone with motor neurone disease (MND) or Kennedy’s disease. You may prefer to see yourself as their partner, relative or friend, but as a ‘carer’ you can access services and support. Getting help may become essential as care needs increase. The following pages provide information to help you look after your own wellbeing.
About ALS
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disease. ALS affects an estimated 350,000 people worldwide, with an average survival rate of three years. The degeneration of nerves leads to muscle weakness and impaired speaking, swallowing, and breathing, eventually causing paralysis and death. Currently, there is no cure.
What is ALS?
In the U.S., someone is diagnosed with ALS every 90 minutes and every 90 minutes someone with ALS dies. ALS (Amyotrophic Lateral Sclerosis) is a rapidly progressive, terminal disease that causes muscle weakness, difficulty speaking and swallowing and, generally, complete paralysis.